 Hypertension, Pulmonary
"Hypertension, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Descriptor ID |
D006976
|
| MeSH Number(s) |
C08.381.423
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Pulmonary".
This graph shows the total number of publications written about "Hypertension, Pulmonary" by people in this website by year, and whether "Hypertension, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 1 | 8 | | 1996 | 9 | 1 | 10 | | 1997 | 11 | 2 | 13 | | 1998 | 22 | 2 | 24 | | 1999 | 15 | 1 | 16 | | 2000 | 10 | 2 | 12 | | 2001 | 14 | 1 | 15 | | 2002 | 17 | 3 | 20 | | 2003 | 15 | 4 | 19 | | 2004 | 25 | 2 | 27 | | 2005 | 36 | 4 | 40 | | 2006 | 21 | 6 | 27 | | 2007 | 25 | 5 | 30 | | 2008 | 25 | 4 | 29 | | 2009 | 32 | 2 | 34 | | 2010 | 27 | 6 | 33 | | 2011 | 36 | 8 | 44 | | 2012 | 34 | 6 | 40 | | 2013 | 41 | 6 | 47 | | 2014 | 37 | 5 | 42 | | 2015 | 43 | 7 | 50 | | 2016 | 43 | 3 | 46 | | 2017 | 40 | 5 | 45 | | 2018 | 32 | 3 | 35 | | 2019 | 36 | 2 | 38 | | 2020 | 44 | 5 | 49 | | 2021 | 37 | 0 | 37 | | 2022 | 35 | 1 | 36 | | 2023 | 35 | 1 | 36 | | 2024 | 25 | 6 | 31 | | 2025 | 20 | 1 | 21 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Preston IR, Badesch D, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Humbert M, McLaughlin VV, Waxman AB, Manimaran S, Mikhailova E, Reddy M, Lau A, de Oliveira Pena J, Souza R. A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA. Eur Respir J. 2025 Jul; 66(1).
-
Long GM, Giourdas AD, Fisher AJ, Lahm T, Coggan AR, Brown MB. Effect of pre-exercise dietary nitrate on skeletal muscle blood flow in a rat model of pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2025 Aug 01; 329(2):R317-R325.
-
Robbins EW, Bradley K, Badesch D, Burger C, Chyboski AM, De Marco T, Hemnes AR, Lammi M, Mathai SC, Melendres-Groves L, Raza F, Sager J, Shlobin O, Thenappan T, Zamanian R, Runo J, Baird GL, Ventetuolo CE. Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR). Ann Am Thorac Soc. 2025 Jun; 22(6):830-837.
-
Montani D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman AB, Escribano Subias P, Feldman J, Meyer GM, Olsson KM, Coulet F, Manimaran S, Zhao Y, Lau A, de Oliveira Pena J, Badesch DB, Humbert M. Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). Am J Respir Crit Care Med. 2025 Jun; 211(6):1028-1037.
-
Simpkin CT, Frank BS, Liu Y, Pan Z, Ivy DD, Burkett DA. Echocardiographic Prediction of Hemodynamics During Acute Vasoreactivity Testing in Pediatric Pulmonary Arterial Hypertension. Echocardiography. 2025 Jun; 42(6):e70232.
-
Shoaibi A, Ostropolets A, Weaver J, Rao GA, Golozar A, Swerdel J, Huser V, Adam A, Alshammari T, Anikpezie N, Baumgartner WA, Brand M, Fan R, Kanter AS, Kern D, Melisa S, Minty E, Mo J, Oluwalade B, Schilling LM, Spence H, Stocking JC, Zhang L, Ryan P. Variation in Phenotype Definitions in Observational Clinical Research: A Review of Three Conditions. AMIA Annu Symp Proc. 2024; 2024:1021-1029.
-
Borhani A, Nia IY, Zandieh G, Mathai SC, Hsu S, Hassoun PM, Kamel IR, Zimmerman SL, Venkatesh BA. Semi-quantitative Analysis of Right Ventricular Myocardial First-pass Perfusion Using Cardiac Magnetic Resonance Imaging in Systemic Sclerosis and Pulmonary Arterial Hypertension. Acad Radiol. 2025 Aug; 32(8):4445-4455.
-
Lewis CV, Nguyen TN, Porfilio TE, Burciaga SD, Posey JN, Jordan M, Colon Hidalgo D, Stenmark KR, Mickael C, Sul C, Oberley-Deegan RE, Delaney C, Nozik ES. Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia. Am J Physiol Lung Cell Mol Physiol. 2025 Jun 01; 328(6):L885-L900.
-
Hoeper MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, Grünig E, Kopec G, McLaughlin VV, Meyer G, Olsson KM, Preston IR, Rosenkranz S, Souza R, Waxman AB, Perchenet L, Strait J, Xing A, Manimaran S, Wang X, Miller B, Cornell AG, de Oliveira Pena J, Ghofrani HA, Humbert M. Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies. Eur Respir J. 2025 May; 65(5).
-
Bailey M, Frantz R, Minhas J, Cascino T, Burger C, Shlobin O, Sager J, Raval A, Lammi M, Runo J, Thenappan T, De Marco T, Ravichandran A, Safdar Z, Lachant D, Badesch D, Yung D, DuBrock H. The Frequency and Predictors of Pulmonary Rehabilitation Referrals Among Patients With Pulmonary Arterial Hypertension: An Analysis of the Pulmonary Hypertension Association Registry. Chest. 2025 Oct; 168(4):996-1006.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|